Home Newsfeeds Goldman Sachs Maintains Neutral on Phathom Pharmaceuticals, Lowers Price Target to $9

Goldman Sachs Maintains Neutral on Phathom Pharmaceuticals, Lowers Price Target to $9

Goldman Sachs analyst Paul Choi maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Neutral and lowers the price target from $15 to $9.

byBenzinga Newsdesk

August 3, 2022

1 minute read

Goldman Sachs analyst Paul Choi maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Neutral and lowers the price target from $15 to $9.

Raymond James Maintains Outperform on Veritex Holdings, Lowers Price Target to $36

By Benzinga Newsdesk

September 13, 4:29 AM

Raymond James analyst Michael Rose maintains Veritex Holdings (NASDAQ:VBTX) with a Outperform and lowers the price target from $38 to $36.

VBTX

Investor Optimism Drops Slightly Despite Dow Recording Best Month Since 1976

By Lisa Levin

November 1, 5:45 AM

The CNN Money Fear and Greed index showed some easing in overall market sentiment after US stocks recorded losses on Monday. The Dow Jones, however, notched its best month since 1976, with all the major indices ending a two-month losing streak.

AMD

What’s Going On With AMC Entertainment Stock?

By Erica Kollmann

August 24, 10:50 AM

AMC Entertainment Holdings, Inc. (NYSE: AMC) shares are trading lower Thursday. The stock began trading on a 10-to-1 reverse split basis at the market open.

$APE

Did You Miss These 3 High-Yielding Dividend Stocks In Financial Sector From Wall Street’s Most Accurate Analysts?

By Avi Kapoor

December 11, 9:14 AM

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

AGNC

Goldman Sachs Maintains Neutral on Phathom Pharmaceuticals, Lowers Price Target to $9

Related Posts

Raymond James Maintains Outperform on Veritex Holdings, Lowers Price Target to $36

Investor Optimism Drops Slightly Despite Dow Recording Best Month Since 1976

What’s Going On With AMC Entertainment Stock?

Did You Miss These 3 High-Yielding Dividend Stocks In Financial Sector From Wall Street’s Most Accurate Analysts?